Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists

[1] Smitherman TA(2013)The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies Headache 53 427-436

[2] Burch R(2017)Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 The Lancet 390 1211-1259

[3] Sheikh H(1999)Burden of migraine in the United States: disability and economic costs Arch Intern Med 159 813-818

[4] Loder E(2007)Migraine prevalence, disease burden, and the need for preventive therapy Neurology 68 343-349

[5] Vos Theo(2007)What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults Neurol Sci 28 S70-S77

[6] Abajobir Amanuel Alemu(2017)Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components BMJ Open 7 65-1183

[7] Abate Kalkidan Hassen(2018)Health behaviors in episodic migraine: why behavior change matters Curr Pain Headache Rep 22 1178-891

[8] Abbafati Cristiana(2007)Behavioral sleep modification may revert transformed migraine to episodic migraine Headache 47 883-465

[9] Abbas Kaja M(2017)Lasting improvement of medication-overuse headache after brief intervention - a long-term follow-up in primary care Eur J Neurol 24 445-1345

[10] Abd-Allah Foad(2009)Behavioral medicine for migraine Neurol Clin 27 61-1826

[1] Smitherman TA(2013)The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies Headache 53 427-436

[2] Burch R(2017)Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 The Lancet 390 1211-1259

[3] Sheikh H(1999)Burden of migraine in the United States: disability and economic costs Arch Intern Med 159 813-818

[4] Loder E(2007)Migraine prevalence, disease burden, and the need for preventive therapy Neurology 68 343-349

[5] Vos Theo(2007)What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults Neurol Sci 28 S70-S77

[6] Abajobir Amanuel Alemu(2017)Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components BMJ Open 7 65-1183

[7] Abate Kalkidan Hassen(2018)Health behaviors in episodic migraine: why behavior change matters Curr Pain Headache Rep 22 1178-891

[8] Abbafati Cristiana(2007)Behavioral sleep modification may revert transformed migraine to episodic migraine Headache 47 883-465

[9] Abbas Kaja M(2017)Lasting improvement of medication-overuse headache after brief intervention - a long-term follow-up in primary care Eur J Neurol 24 445-1345

[10] Abd-Allah Foad(2009)Behavioral medicine for migraine Neurol Clin 27 61-1826